H.E.A.R. for Postpartum Complications
(HEAR4Mamas Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests different ways to help new mothers identify and manage health issues after giving birth. It compares two methods: an in-person education program and a tech-based program called H.E.A.R. for Mamas, which uses texts or phone calls. The researchers aim to determine which method better supports women in the first six weeks after delivery, especially those facing health disparities. New mothers in South Carolina who are on Medicaid and speak English or Spanish may qualify for this study. As an unphased trial, this study offers a unique opportunity to contribute to improving postpartum care for new mothers.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the H.E.A.R. for Mamas protocol is safe for postpartum women?
Research has shown that the H.E.A.R. for Mamas program uses simple text messages and phone calls to monitor new mothers for any post-childbirth issues. Designed with input from both mothers and healthcare providers, the program aims to identify problems early so women can receive timely care.
The program reduces post-birth risks by regularly checking for warning signs, helping mothers access medical help promptly, which could save lives. Although specific data on the safety of the H.E.A.R. program is not available, technology-based regular check-ins are generally safe and well-received. This non-invasive method relies on texts or calls for communication, avoiding medical procedures.12345Why are researchers excited about this trial?
Researchers are excited about the H.E.A.R. for Mamas program because it introduces a new way to monitor and educate women after childbirth. Unlike the usual postpartum care, which typically involves in-person visits and standard safety guidelines, H.E.A.R. for Mamas uses patient-centered technology like text and phone communications. This approach allows for more frequent and systematic monitoring of postpartum complications, potentially catching issues earlier and providing timely interventions. By integrating this innovative tech-based system, the program aims to enhance postpartum care and improve outcomes for new mothers.
What evidence suggests that the H.E.A.R. for Mamas protocol is effective for postpartum complications?
Research has shown that the H.E.A.R. for Mamas program, available to participants in this trial, can identify health problems after childbirth. This program uses simple methods, such as texts and phone calls, to monitor new mothers for signs of issues. Studies have found that this type of communication helps women receive necessary care promptly. The program aims to make postpartum care more accessible and timely, which is crucial for preventing serious health problems. Overall, evidence suggests that H.E.A.R. for Mamas could effectively improve health outcomes for new mothers.12567
Are You a Good Fit for This Trial?
This trial is for postpartum women aged 18-45 who have recently given birth and are admitted to the Roper St. Francis HealthCare Postpartum Unit. Participants must be within approximately one week of delivering a live birth and insured by Medicaid.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive AIM safety bundles either in-person or via text/phone to monitor postpartum complications
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- H.E.A.R. for Mamas
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator